Physician profile
Barry Brook
NPI 1215993779
$11,368.15
in general payments reported to CMS, 2019-2025
57 companies · $600 in 2025
The $600 reported for 2025 was more than what 77% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,850 · 2020: $2,025 · 2021: $2,416 · 2022: $2,231 · 2023: $1,460 · 2024: $786 · 2025: $600.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,846.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,846.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $1,503.87 | 2019-2025 | Breztri, Airsupra, Farxiga |
| Abbvie INC. | $1,218.18 | 2019-2025 | Qulipta, Linzess, Ubrelvy |
| Pfizer INC. | $1,182.12 | 2019-2025 | |
| Novo Nordisk INC | $1,019.64 | 2019-2023 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $689.28 | 2019-2024 | Trelegy Ellipta, Arexvy |
| Abbott Laboratories | $656.49 | 2021-2024 | Freestyle Libre 3, Freestyle Libre 2 |
| Lilly USA, LLC | $388.22 | 2019-2023 | Mounjaro, Jardiance |
| Novartis Pharmaceuticals Corporation | $356.90 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $351.03 | 2019-2023 | Xarelto |
| Merck Sharp & Dohme LLC | $347.31 | 2019-2022 | |
| Teva Pharmaceuticals USA, INC. | $317.95 | 2019-2023 | Austedo Xr |
| Exact Sciences Corporation | $293.89 | 2023-2025 | Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $287.04 | 2019-2023 | Synjardy, Jardiance |
| Amarin Pharma, INC. | $243.77 | 2019-2022 | |
| Amgen INC. | $236.03 | 2019-2022 |
Show all 57 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barry Brook listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.